Palantir Q2 2026: The $6.24 Billion Backlog Number Matters More Than 93% Revenue Growth
Palantir reported second-quarter revenue of $1.94 billion against a $1.81 billion consensus, up 93 percent year over year, and every headline led with that growth rate. It is the wrong number to anchor on. The figure that determines whether this quarter is an inflection or a peak is the $6.24 billion in remaining U.S. commercial deal value, more than double the year-ago level and roughly eight times what the segment actually recognized in the three months just ended. Revenue growth tells you what already closed. Remaining deal value tells you what has been signed and not yet billed, and at that coverage ratio the 149 percent U.S. commercial growth rate is not a comp artifact waiting to unwind. It is a conversion schedule.
The sequential figures matter more than the annual ones here, because year-over-year comparisons against a small base flatter everything in this cohort. U.S. commercial revenue reached $764 million, up 28 percent from the prior quarter. U.S. government revenue grew 18 percent sequentially. Total U.S. business now exceeds 81 percent of revenue and expanded 23 percent quarter on quarter. First-quarter results carried an unexplained deceleration in commercial bookings that Citi flagged at the time and that contributed to the stock falling 14 percent on a 22 percent earnings beat. That deceleration reversed completely. Whatever the first quarter was, it was not the start of a trend.
Profitability scaled with it rather than against it. GAAP operating income came in at $912 million on a 47 percent margin, adjusted operating income at $1.19 billion on 62 percent, and net income at $1.07 billion versus roughly $329 million a year earlier. Adjusted earnings of $0.41 per share beat the $0.35 consensus and extended the beat streak to nine quarters. The Rule of 40 score reached 155. That combination is the actual evidence for the moat argument, and it is worth stating precisely why. Palantir’s competitive advantage has never been model quality, and the company does not claim it is. The advantage is the ontology layer, the forward-deployed engineering motion that maps a customer’s operational reality into it, and, on the government side, accreditation and program-of-record status that competitors cannot buy their way into on a procurement cycle. Maven Smart System becoming a Pentagon program of record and the Army’s Next Generation Command and Control selection are structural, not transactional.
The bear case against that moat is straightforward: forward-deployed engineering is labor, labor has real marginal cost, and OpenAI and Anthropic are pushing enterprise tooling into the same territory Foundry and AIP occupy. The 62 percent adjusted operating margin is the counterargument. If deployment labor scaled linearly with revenue, margins would compress as the customer count grew. They expanded while revenue nearly doubled. That is what a genuine platform effect looks like in the income statement rather than in the shareholder letter. The model-agnostic orchestration point that D.A. Davidson’s Gil Luria made when upgrading the stock follows from the same logic: every improvement in frontier models is an input cost decline for Palantir, not a competitive threat, because the switching layer sits above the models. The residual risk is commercial, not governmental. Government switching costs are close to prohibitive. Commercial ontology work is a data-modeling exercise that a sufficiently motivated systems integrator could eventually approximate, and that is where any erosion appears first.
Guidance is where management showed its hand. Full-year revenue moved to $8.150 to $8.158 billion from $7.650 to $7.662 billion, a raise of roughly half a billion dollars in a single quarter, implying 82 percent annual growth. U.S. commercial guidance went to above $3.424 billion from $3.22 billion, at least 134 percent growth. Adjusted free cash flow is now $4.50 to $4.70 billion. The third-quarter guide of $2.160 to $2.164 billion implies 11 percent sequential growth against the 19 percent just delivered, and the company beat its own second-quarter midpoint by nearly 8 percent. Applying that same sandbag to the third quarter produces something closer to $2.33 billion. The implied fourth quarter of roughly $2.42 billion carries the same conservatism. Take the guide as a floor.
The stock went into the print down about 30 percent year to date and roughly 40 percent below its high, closing at $123.06 the previous Friday and trading near $131 into the close on results day. It rose nearly 10 percent after hours to $137.85. Market capitalization sat at $295 billion at the end of July and moves to roughly $330 billion on that gain. The derating is the story of 2026 for this name: nine consecutive beats and accelerating fundamentals while the multiple compressed from above 60 times forward revenue to roughly 40 times on the newly raised guide, or about 72 times adjusted free cash flow. Investors have spent seven months selling a company that kept compounding faster than the multiple contracted.
Street targets sit well above the current price. Oppenheimer, Citi, and Baird all carry $200, Wedbush $230, D.A. Davidson $175, with a consensus near $181 to $190. RBC’s Rishi Jaluria holds an Underperform at $90. Michael Burry has held puts since late 2025 and argues fair value is below $50.
Base case is $150 to $170, requiring only that the multiple stop contracting while the raised guide converts and the technical breakout above $131 holds toward the $145 to $151 zone. Bull case is $200 to $230, and it needs U.S. commercial to clear $3.42 billion for the year, an initial 2027 revenue frame above $12.5 billion, and international sovereign AI contracts to relieve the digital-sovereignty drag that has capped non-U.S. growth. Bear case is $85 to $105, and note carefully that it is not a Palantir-specific thesis. It is cohort derating. If the AI software complex resets again on disruption fear, Palantir carries the highest multiple in the group and therefore absorbs the most damage per unit of sentiment, regardless of what the print says. The first downside marker is $106, then $83.
One number decides which of those paths runs. Remaining U.S. commercial deal value of $6.24 billion against $764 million of quarterly U.S. commercial revenue. If that coverage ratio holds through the third quarter, the acceleration is contracted rather than cyclical, and the current multiple is the cheapest this business has traded at relative to its own forward book.